Antibody Drug Conjugates

Products

Information

Syngene's Antibody Drug Conjugate (ADC) unit brings together an array of multidisciplinary capabilities in antibody generation, linker and payload chemistry, conjugation chemistry, in vitro and in vivo oncology in an integrated platform.
All categories
AntibodiesAPIs (Active Pharmaceutical Ingredients)Innovative APIsProducts
Main Categories
APIs (Active Pharmaceutical Ingredients)
Syngene International Ltd.Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organisation providing scientific services -- from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies

Log in

See all the content and easy-to-use features by logging in or registering!